The 2018 Korean Heart Rhythm Society Practical Guidelines on the use of Non-Vitamin K-Antagonist Oral Anticoagulants: Bleeding Control and Perioperative Management
- Author:
Ji Hyun LEE
1
;
Hong Euy LIM
;
Woo Hyun LIM
;
Jinhee AHN
;
Myung Jin CHA
;
Junbeom PARK
;
Ki Hong LEE
;
Hwan Cheol PARK
;
Eue Keun CHOI
;
Boyoung JOUNG
Author Information
- Publication Type:Review
- Keywords: Atrial fibrillation; Anticoagulants; Guideline; Perioperative care; Hemorrhage
- MeSH: Anticoagulants; Atrial Fibrillation; Heart; Hemorrhage; Humans; Perioperative Care; Warfarin
- From:Korean Journal of Medicine 2019;94(1):40-56
- CountryRepublic of Korea
- Language:Korean
- Abstract: Although non-vitamin K-antagonist oral anticoagulants (NOACs) reduce major bleeding events in patients with atrial fibrillation more effectively than does warfarin, a significant bleeding risk remains. Patients exhibiting current bleeding and those who are expected to bleed require appropriate management, because NOAC discontinuation may increase the thromboembolic risk. This article details general management principles for patients experiencing current bleeding and those undergoing invasive surgery while on NOACs.
